Research-Grade Somatropin Overview
OMNITROPE 10 MG Pharma Grade is a recombinant human growth hormone formulation produced under pharmaceutical manufacturing standards. This somatropin preparation contains 191 amino acids in the identical sequence to endogenous human growth hormone, making it valuable for researchers investigating growth hormone receptor interactions, signal transduction pathways, and cellular responses in laboratory settings. Research teams at Stroid UK Shop can examine this compound’s effects on protein synthesis, lipolysis, and glucose metabolism through controlled in-vitro studies.
Laboratory Research Applications
Scientists study OMNITROPE to analyse growth hormone receptor binding kinetics and downstream signalling cascades. Research applications include investigating IGF-1 pathway activation, examining growth hormone’s role in cellular metabolism, and evaluating receptor selectivity mechanisms. Laboratory studies focus on the compound’s interaction with growth hormone binding proteins and its effects on gene expression profiles in cell culture systems. Researchers compare this pharmaceutical-grade preparation with other compounds available in the growth hormone category to evaluate structural differences and biological activity profiles.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Recombinant Human Growth Hormone |
| Molecular Weight | 22.12 kDa |
| Amino Acid Count | 191 residues |
| Presentation | 10 mg vial |
| Manufacturing Standard | Pharmaceutical grade |
| Storage Requirements | 2-8°C refrigeration |
Unlike peptide research compounds found in our peptides section or receptor modulators in the SARMs collection, OMNITROPE represents a full-length protein hormone requiring specialized handling protocols for research applications.
Research Compliance Statement
OMNITROPE 10 MG Pharma Grade is supplied exclusively for in-vitro research and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must follow institutional guidelines for handling recombinant proteins and maintain appropriate storage conditions to preserve compound integrity for experimental purposes only.
